Cargando…

Protective Effects of the Soluble Epoxide Hydrolase Inhibitor 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea in a Rat Model of Permanent Middle Cerebral Artery Occlusion

Acute ischemic stroke is a serious disease that endangers human health. In our efforts to develop an effective therapy, we previously showed that the potent, highly selective inhibitor of soluble epoxide hydrolase called 1-trifuoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) protects the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Linlei, Xu, Shasha, Wu, Xiaoxiao, Muse, Farah Mohamed, Chen, Jiaou, Cao, Yungang, Yan, Jueyue, Cheng, Zicheng, Yi, Xingyang, Han, Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058996/ https://www.ncbi.nlm.nih.gov/pubmed/32184732 http://dx.doi.org/10.3389/fphar.2020.00182

Ejemplares similares

A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis
por: Jonnalagadda, Deepa, et al.
Publicado: (2021)

1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation In Vivo and In Vitro Model
por: Yi, Xingyang, et al.
Publicado: (2020)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
por: Wan, Debin, et al.
Publicado: (2019)

Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood–Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion
por: Zhang, Linlei, et al.
Publicado: (2020)

Mycobacterial Epoxide Hydrolase EphD Is Inhibited by Urea and Thiourea Derivatives
por: Madacki, Jan, et al.
Publicado: (2021)

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales
por: Kitamura, Seiya, et al.
Publicado: (2017)

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors
por: Gur Maz, Tugce, et al.
Publicado: (2023)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Epoxide Hydrolases: Multipotential Biocatalysts
por: Bučko, Marek, et al.
Publicado: (2023)

Conformational diversity and enantioconvergence in potato epoxide hydrolase 1
por: Bauer, P., et al.
Publicado: (2016)

Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022)

Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases
por: Arand, Michael, et al.
Publicado: (2017)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019)

The crystal structure of mycobacterial epoxide hydrolase A
por: Schulz, Eike C., et al.
Publicado: (2020)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
por: Domingues, Michelle Flores, et al.
Publicado: (2020)

Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase
por: Moghaddam, Mehran F., et al.
Publicado: (1997)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Goldberg, Daniel E., et al.
Publicado: (2017)

Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors
por: Codony, Sandra, et al.
Publicado: (2022)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes
por: Nelson, Jonathan W., et al.
Publicado: (2016)

Expanding the Catalytic Triad in Epoxide Hydrolases and Related Enzymes
por: Amrein, Beat A., et al.
Publicado: (2015)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

The role of soluble epoxide hydrolase and its inhibitors in depression
por: Borsini, Alessandra
Publicado: (2021)

The Multifaceted Role of Epoxide Hydrolases in Human Health and Disease
por: Gautheron, Jérémie, et al.
Publicado: (2020)

Synthesis of 1-(4-Trifluoromethoxyphenyl)-2,5-dimethyl-3-(2-R-thiazol-4-yl)-1H-pyrroles via Chain Heterocyclization
por: Vovk, Mykhaylo V., et al.
Publicado: (2010)

Soluble Epoxide Hydrolase Inhibitors Regulate Ischemic Arrhythmia by Targeting MicroRNA-1
por: Chen, Yanying, et al.
Publicado: (2021)

Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity
por: Oh, Young Taek, et al.
Publicado: (2023)

Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk
por: Gsur, A, et al.
Publicado: (2003)

Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
por: Harrison, D J, et al.
Publicado: (1999)

The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics.
por: Seidegård, J, et al.
Publicado: (1997)

Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
por: Brenneis, Christian, et al.
Publicado: (2011)

Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014)

Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice
por: Qin, Jun, et al.
Publicado: (2015)

Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa
por: Shih, Pei-an Betty, et al.
Publicado: (2015)

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators
por: Tripathi, Neetika, et al.
Publicado: (2018)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019)

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
por: Shan, Jiajing, et al.
Publicado: (2022)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
por: Kim, Jang Hoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2r03a3thqh7mue73m9rrj9p0e